Cart
sales@molnova.com
BAY-4931
CAS No. 423150-91-8
BAY-4931( —— )
Catalog No. M36091 CAS No. 423150-91-8
BAY-4931 is a powerful, covalent, and selective inverse-agonist of PPARγ, exhibiting an IC50 value of 0.17 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 93 | In Stock |
|
| 5MG | 76 | In Stock |
|
| 10MG | 122 | In Stock |
|
| 25MG | 275 | In Stock |
|
| 50MG | 423 | In Stock |
|
| 100MG | 625 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 1330 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBAY-4931
-
NoteResearch use only, not for human use.
-
Brief DescriptionBAY-4931 is a powerful, covalent, and selective inverse-agonist of PPARγ, exhibiting an IC50 value of 0.17 nM.
-
DescriptionBAY-4931 is a potent, covalent and selective PPARγ inverse-agonist with an IC50 of 0.17 nM.
-
In VitroBAY-4931 (0-10 μM; 7 days) inhibits UM-UC-9 proliferation with an IC50 of 3.4 nM.BAY-4931 only inhibits CYP2C8 in CYP inhibition test.Cell Proliferation Assay Cell Line:UM-UC-9 cells Concentration:0-10 μM Incubation Time:7 days Result:Inhibited proliferation with an IC50 of 3.4 nM.
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetPPAR
-
RecptorPPAR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number423150-91-8
-
Formula Weight421.83
-
Molecular FormulaC22H16ClN3O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (296.33 mM; Ultrasonic (<70°C)
-
SMILESN(C(=O)C1=CC(N(=O)=O)=CC=C1Cl)C=2C=C3C(OC(=N3)C4=CC=C(CC)C=C4)=CC2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Orsi DL, et al. Discovery and Structure-Based Design of Potent Covalent PPARγ Inverse-Agonists BAY-4931 and BAY-0069. J Med Chem. 2022 Nov 10;65(21):14843-14863.?
molnova catalog
related products
-
K-111
K-111 (BM-170744) is an orally available peroxisome proliferator-activated receptor (PPAR)-alpha agonist and insulin enhancer for the study of obesity-type diabetes mellitus and the metabolic syndrome.
-
Dihydrocurcumin
Dihydrocurcumin is the main metabolite of curcumin, which can reduce fat accumulation and oxidative stress response.
-
4'-Methoxychalcone
4'-Methoxychalcone with a variety of pharmacological activities such as anti-tumor and anti-inflammatory activities.
